Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

AIMS: SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. METHODS: Virus binds to the cell surface receptor ACE2; indeed, recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Solerte, Sebastiano Bruno, Di Sabatino, Antonio, Galli, Massimo, Fiorina, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275134/
https://www.ncbi.nlm.nih.gov/pubmed/32506195
http://dx.doi.org/10.1007/s00592-020-01539-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275134/
https://www.ncbi.nlm.nih.gov/pubmed/32506195
http://dx.doi.org/10.1007/s00592-020-01539-z

Ejemplares similares